BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 30068552)

  • 21. A unique FGF23 with the ability to activate FGFR signaling through both αKlotho and βKlotho.
    Wu X; Weiszmann J; Ge H; Baribault H; Stevens J; Hawkins N; Vonderfecht S; Gardner J; Gupte J; Sheng J; Wang M; Li Y
    J Mol Biol; 2012 Apr; 418(1-2):82-9. PubMed ID: 22370560
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relevant use of Klotho in FGF19 subfamily signaling system in vivo.
    Tomiyama K; Maeda R; Urakawa I; Yamazaki Y; Tanaka T; Ito S; Nabeshima Y; Tomita T; Odori S; Hosoda K; Nakao K; Imura A; Nabeshima Y
    Proc Natl Acad Sci U S A; 2010 Jan; 107(4):1666-71. PubMed ID: 20080590
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Paracrine FGFs target skeletal muscle to exert potent anti-hyperglycemic effects.
    Ying L; Wang L; Guo K; Hou Y; Li N; Wang S; Liu X; Zhao Q; Zhou J; Zhao L; Niu J; Chen C; Song L; Hou S; Kong L; Li X; Ren J; Li P; Mohammadi M; Huang Z
    Nat Commun; 2021 Dec; 12(1):7256. PubMed ID: 34907199
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association between insulin resistance and impairment of FGF21 signal transduction in skeletal muscles.
    Jeon JY; Choi SE; Ha ES; Kim TH; Jung JG; Han SJ; Kim HJ; Kim DJ; Kang Y; Lee KW
    Endocrine; 2016 Jul; 53(1):97-106. PubMed ID: 26758997
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The FGFR D3 domain determines receptor selectivity for fibroblast growth factor 21.
    Gupte J; Yang L; Wu X; Weiszmann J; Hecht R; Lemon B; Lindberg R; Wang Z; Li Y
    J Mol Biol; 2011 May; 408(3):491-502. PubMed ID: 21392510
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Opposite alterations in FGF21 and FGF19 levels and disturbed expression of the receptor machinery for endocrine FGFs in obese patients.
    Gallego-Escuredo JM; Gómez-Ambrosi J; Catalan V; Domingo P; Giralt M; Frühbeck G; Villarroya F
    Int J Obes (Lond); 2015 Jan; 39(1):121-9. PubMed ID: 24813368
    [TBL] [Abstract][Full Text] [Related]  

  • 27. FGF21 mimetic antibody stimulates UCP1-independent brown fat thermogenesis via FGFR1/βKlotho complex in non-adipocytes.
    Chen MZ; Chang JC; Zavala-Solorio J; Kates L; Thai M; Ogasawara A; Bai X; Flanagan S; Nunez V; Phamluong K; Ziai J; Newman R; Warming S; Kolumam G; Sonoda J
    Mol Metab; 2017 Nov; 6(11):1454-1467. PubMed ID: 29107292
    [TBL] [Abstract][Full Text] [Related]  

  • 28. FGF21 in obesity and cancer: New insights.
    Lu W; Li X; Luo Y
    Cancer Lett; 2021 Feb; 499():5-13. PubMed ID: 33264641
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Klotho gene family as a regulator of endocrine fibroblast growth factors.
    Kurosu H; Kuro-O M
    Mol Cell Endocrinol; 2009 Feb; 299(1):72-8. PubMed ID: 19063940
    [TBL] [Abstract][Full Text] [Related]  

  • 30. α-Klotho's effects on mineral homeostasis are fibroblast growth factor-23 dependent.
    Erben RG
    Curr Opin Nephrol Hypertens; 2018 Jul; 27(4):229-235. PubMed ID: 29851418
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metformin Improves the Prerequisites for FGF21 Signaling in Patients With Type 2 Diabetes.
    Pedersen AKN; Gormsen LC; Nielsen S; Jessen N; Bjerre M
    J Clin Endocrinol Metab; 2024 Jan; 109(2):e552-e561. PubMed ID: 37776319
    [TBL] [Abstract][Full Text] [Related]  

  • 32. FGF21 Protects the Blood-Brain Barrier by Upregulating PPARγ via FGFR1/β-klotho after Traumatic Brain Injury.
    Chen J; Hu J; Liu H; Xiong Y; Zou Y; Huang W; Shao M; Wu J; Yu L; Wang X; Wang X; Lin L
    J Neurotrauma; 2018 Sep; 35(17):2091-2103. PubMed ID: 29648978
    [TBL] [Abstract][Full Text] [Related]  

  • 33.
    Xu C; Messina A; Somm E; Miraoui H; Kinnunen T; Acierno J; Niederländer NJ; Bouilly J; Dwyer AA; Sidis Y; Cassatella D; Sykiotis GP; Quinton R; De Geyter C; Dirlewanger M; Schwitzgebel V; Cole TR; Toogood AA; Kirk JM; Plummer L; Albrecht U; Crowley WF; Mohammadi M; Tena-Sempere M; Prevot V; Pitteloud N
    EMBO Mol Med; 2017 Oct; 9(10):1379-1397. PubMed ID: 28754744
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thyroid Hormone-Induced Expression of the Hepatic Scaffold Proteins Sestrin2, β-Klotho, and FRS2α in Relation to FGF21-AMPK Signaling.
    Videla LA; Vargas R; Riquelme B; Fernández J; Fernández V
    Exp Clin Endocrinol Diabetes; 2018 Mar; 126(3):182-186. PubMed ID: 28895643
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of a crucial amino acid responsible for the loss of specifying FGFR1-KLB affinity of the iodinated FGF21.
    Luo W; Lin XM; Wang TX; Cai JL; Zeng XF; Zhu CR; Li RZ; Wang H; Wu XP
    J Cell Physiol; 2019 Mar; 234(3):2500-2510. PubMed ID: 30317562
    [TBL] [Abstract]